NO960425L - 15,15-dialkyl-substituerte derivater av östradiol - Google Patents

15,15-dialkyl-substituerte derivater av östradiol

Info

Publication number
NO960425L
NO960425L NO960425A NO960425A NO960425L NO 960425 L NO960425 L NO 960425L NO 960425 A NO960425 A NO 960425A NO 960425 A NO960425 A NO 960425A NO 960425 L NO960425 L NO 960425L
Authority
NO
Norway
Prior art keywords
carbon atoms
estradiol
dialkyl
group
substituted derivatives
Prior art date
Application number
NO960425A
Other languages
English (en)
Norwegian (no)
Other versions
NO960425D0 (no
Inventor
James Ronald Bull
Karl-Heinrich Fritzemeier
Christa Hegele-Hartung
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO960425D0 publication Critical patent/NO960425D0/no
Publication of NO960425L publication Critical patent/NO960425L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO960425A 1993-08-02 1996-02-01 15,15-dialkyl-substituerte derivater av östradiol NO960425L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4326240A DE4326240A1 (de) 1993-08-02 1993-08-02 15,15-Dialkyl-substituierte Derivate des Estradiols
PCT/EP1994/002540 WO1995004070A1 (en) 1993-08-02 1994-08-01 15,15-dialkyl-substituted derivatives of estradiol

Publications (2)

Publication Number Publication Date
NO960425D0 NO960425D0 (no) 1996-02-01
NO960425L true NO960425L (no) 1996-04-02

Family

ID=6494482

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960425A NO960425L (no) 1993-08-02 1996-02-01 15,15-dialkyl-substituerte derivater av östradiol

Country Status (21)

Country Link
US (2) US5587496A (de)
EP (1) EP0712412B1 (de)
JP (1) JPH09500891A (de)
KR (1) KR960703940A (de)
CN (1) CN1040329C (de)
AT (1) ATE175418T1 (de)
AU (1) AU674609B2 (de)
CA (1) CA2168657A1 (de)
CZ (1) CZ26796A3 (de)
DE (2) DE4326240A1 (de)
FI (1) FI960465A7 (de)
HU (1) HUT73238A (de)
IL (1) IL110530A (de)
MY (1) MY111121A (de)
NO (1) NO960425L (de)
NZ (1) NZ271091A (de)
PL (1) PL312792A1 (de)
RU (1) RU2147306C1 (de)
SK (1) SK13596A3 (de)
WO (1) WO1995004070A1 (de)
ZA (1) ZA945754B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4326240A1 (de) * 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols
DE4447401A1 (de) 1994-12-23 1996-07-04 Schering Ag 14,17-C¶2¶-überbrückte Steroide
DE19906159A1 (de) * 1999-02-09 2000-08-10 Schering Ag 16-Hydroxyestratriene als selektiv wirksame Estrogene
DE10151365A1 (de) * 2001-10-17 2003-04-30 Schering Ag 17-Chlor-D-Homosteroide als selektive Estrogenrezeptorantagonisten
MY142989A (en) * 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
DE602005014227D1 (de) * 2004-03-10 2009-06-10 Bayer Schering Pharma Ag Zusammensetzungen aus drospirenon in molekularer dispersion
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2275752A (en) * 1938-11-25 1942-03-10 Ciba Pharm Prod Inc Cyclic condensation products and process of making same
US3472881A (en) * 1965-05-14 1969-10-14 Merck & Co Inc 3 - hydroxy - 13 - lower alkyl - 15 - carboxyl - 1,3,5(10),8,14 - gonapentaen - 17-ones and intermediates in the production thereof
US3766224A (en) * 1971-06-03 1973-10-16 Sandoz Ag 15-methyl-substituted steroids
DD145919B1 (de) * 1978-06-28 1982-06-30 Kurt Ponsold Verfahren zur herstellung von 14,1 -methylenderivaten der oestranreihe
DE3628189A1 (de) * 1986-08-20 1988-02-25 Schering Ag Oestrogen wirksame mittel und 14,17ss-ethano-14ss-estratriene
DE4326240A1 (de) * 1993-08-02 1995-02-09 Schering Ag 15,15-Dialkyl-substituierte Derivate des Estradiols

Also Published As

Publication number Publication date
NO960425D0 (no) 1996-02-01
DE69415812D1 (de) 1999-03-18
EP0712412B1 (de) 1999-01-07
KR960703940A (ko) 1996-08-31
CN1040329C (zh) 1998-10-21
HU9600234D0 (en) 1996-04-29
PL312792A1 (en) 1996-05-13
HUT73238A (en) 1996-07-29
CZ26796A3 (en) 1996-07-17
CN1128031A (zh) 1996-07-31
SK13596A3 (en) 1997-03-05
ATE175418T1 (de) 1999-01-15
MY111121A (en) 1999-08-30
FI960465A0 (fi) 1996-02-01
EP0712412A1 (de) 1996-05-22
AU7461094A (en) 1995-02-28
FI960465L (fi) 1996-02-01
CA2168657A1 (en) 1995-02-09
WO1995004070A1 (en) 1995-02-09
JPH09500891A (ja) 1997-01-28
IL110530A (en) 1998-08-16
FI960465A7 (fi) 1996-02-01
AU674609B2 (en) 1997-01-02
RU2147306C1 (ru) 2000-04-10
US5656622A (en) 1997-08-12
ZA945754B (en) 1995-03-15
NZ271091A (en) 1996-08-27
DE69415812T2 (de) 1999-09-16
US5587496A (en) 1996-12-24
DE4326240A1 (de) 1995-02-09
IL110530A0 (en) 1994-11-11

Similar Documents

Publication Publication Date Title
DE3570038D1 (en) Steroids for use as immunomodulators
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
IL75337A (en) Polyenoic acids omega-substituted by a 4,5-dimethoxy-2-methyl-quinone or a 4,5-dimethoxy-2-methyl-phenyl group,process for the preparation thereof and pharmaceutical compositions containing the same
NO954681L (no) Kjemiske forbindelser
IL96636A0 (en) Piperidine derivatives and pharmaceutical compositions containing them
IL87657A (en) Preparation of methylene derivatives of androsta-1,4-diene-3,17-dione and pharmaceutical compositions containing them
IL88396A (en) Preparation of 6-methylene derivatives of androsta-1,4- diene-3,17-diones and pharmaceutical compositions containing them
IL76538A0 (en) Alkylpiperazino substituted indane derivatives and methods of preparation and treatment and pharmaceutical compositions containing them
GR1002384B (el) Μεθοδος παρασκευης παραγωγων υποκατεστημενου στυρολιου.
NZ224638A (en) 1-(2',3'-dideoxy-2'-fluoro-beta-d-arabinofuranosyl)- cytosine derivatives and pharmaceutical compositions
EP0158340A3 (en) Novel 1,5-benzothiazepine derivative, processes for preparing the same and pharmaceutical compositions
DK186788A (da) 14,17beta-ethano-14beta-oestratriener og oestratetraener, fremgangsmaader til deres fremstilling og farmaceutiske praeparater indeholdende dem
AU7461094A (en) 15,15-dialkyl-substituted derivatives of estradiol
AU588315B2 (en) Novel isoxazole derivatives, a process for their preparation and pharmaceutical products containing these
DE3572648D1 (en) Halogen labeled compounds including estradiol derivatives, their synthetic intermediates and the syntheses thereof
PT86283A (fr) Procede de preparation de nouveaux produits steroides comportant en position 23 un radical sulfinyle
US3917833A (en) Amino-substituted benzocycloheptenones for inducing sleep
AU7895087A (en) Antigestagens for the inhibition of uterine synthesis of prostaglandin
NO855383L (no) Fremgangsmaate for fremstilling av piperazin-derivater.
ES8204741A1 (es) Procedimiento para la preparacion de 3-desoxi-a15-esteroides
GR3000773T3 (en) 2,2;6,6-diethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactones, process for their preparation and pharmaceutical compositions containing them
GB1502337A (en) 6-aminochroman derivatives and a process for their preparation
EP0324184A3 (en) 2-amino-1,2,3,4-tetrahydroisoquinoline derivatives, method for their preparation and their use as medicines
MY101746A (en) 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof.
BE903194A (fr) Nouveaux steroides et leur preparation